Results 101 to 110 of about 462 (190)

The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC. [PDF]

open access: yesCancer Res Commun, 2023
Weidhaas JB   +19 more
europepmc   +1 more source

Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma. [PDF]

open access: yesCurr Oncol
Williamson J   +18 more
europepmc   +1 more source

Archaeomusicology and Cross-Cultural Comparisons of Reed Instruments in Greco-Roman Antiquity: From the Aulos to the Bagpipes

open access: yes
The aulos was a notable reed instrument in ancient Greek and Roman music, one significant but poorly documented variation of which was the bagpipe from the late Hellenistic period; this thesis will focus on the enigmatic bagpipe and its relationship to ...
Evankovich, Alexandra
core  

Sirene nell'Ade. L'aulo, la lira e il lutto

open access: yes, 2016
Although music might seem to have nothing to do with death and the grief caused by it (to ban any music making from one’s house is a distinctive feature of mourning), yet dirges (threnoi) bestow upon the deceased both praise and the possibility to be ...
PROVENZA, Antonietta
core  

IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors. [PDF]

open access: yesCancer Res Commun
Powderly J   +20 more
europepmc   +1 more source

Orff-pedagogiikka yläkoulussa ja lukiossa

open access: yes, 2017
Aiheenani on Orff-pedagogiikan käyttö yläkoulussa ja lukiossa. Kiinnostuin aiheesta huomatessani, että Orff-pedagogiikkaa käytetään lähinnä varhaisiän musiikkikasvatuksessa, kuten musiikkileikkikoulussa ja alakoulun musiikinopetuksessa, mutta ei ...
Aulos, Jade
core  

First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors. [PDF]

open access: yesOncologist
Powderly JD   +9 more
europepmc   +1 more source

First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation. [PDF]

open access: yesJ Clin Oncol
Baldini C   +21 more
europepmc   +1 more source

Proceedings of the seventh annual Women in Melanoma Conference. [PDF]

open access: yesTher Adv Med Oncol
Najjar YG   +25 more
europepmc   +1 more source

First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors. [PDF]

open access: yesOncologist
Gutierrez ME   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy